Trial Profile
The Safety Assessment of Vedolizumab During Pregnancy in IBD Patient
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- 30 Apr 2019 Status changed from recruiting to not stated.
- 05 Mar 2019 Results published in the American Journal of Gastroenterology
- 04 Dec 2015 New trial record